表观遗传调节,特别是乳腺癌中的基因组修饰:一个可行的和新兴的向治疗策略
Yibing Zhou1, Haotian Liu2, Weimin Hong3
1Central Laboratory, Department of Scientific Research, Changshu Hospital Affiliated to Soochow University, Changshu No.1 People's Hospital, Changshu, 215500, Jiangsu Province, China.
Journal of Cancer
|October 6, 2025
概括
表观遗传调节,特别是基因组修饰,影响乳腺癌的进展和治疗反应. 针对这些表观遗传因素为乳腺癌提供了有前途的新治疗策略.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 表观遗传调节改变基因表达而不改变DNA序列.
- 失调的表观遗传机制,包括基因素修饰,都与乳腺癌的发病和进展有关.
- 基因组基因组稳定性,DNA修复和乳腺癌中的染色质动力学都需要基因组基因组修改.
研究的目的:
- 审查关于乳腺癌表观遗传调节因素的当前研究.
- 专注于组织蛋白修饰在乳腺癌治疗中的作用.
- 探索表观遗传修饰对放射治疗和化疗疗效的影响.
主要方法:
- 关于乳腺癌表观遗传调节因素的文献综述.
- 分析乳腺癌治疗中的组素修饰.
- 检查表观遗传修饰和癌症疗法之间的相互作用.
主要成果:
- 基斯修饰显著影响乳腺癌的发病,进展和治疗结果.
- 表观遗传改变可以抑制或增强驱动乳腺癌的基因表达.
- 放射治疗和化疗的有效性是由表观遗传变化所调节的.
结论:
- 表观遗传调节因素,特别是基因组修饰,在乳腺癌中至关重要.
- 了解这些机制可以改善当前的乳腺癌治疗方法.
- 表观遗传点对开发新型乳腺癌疗法具有重大潜力.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
Histone Modification
4.4K
4.4K
Histone Modification
15.9K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
15.9K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K


